GeneDx, a rare disease diagnosis company, has appointed Linda Genen, MD, MPH as Chief Medical Officer to strengthen the company’s commitment to delivering earlier answers and better outcomes for families through genomic insights. Genen will oversee Medical and Clinical Affairs, lead the company’s clinical strategy, and champion adoption of genomic medicine across health systems, payers, policymakers, and the broader medical community. She will work closely with GeneDx’s executive team to acce...